Exploring synergistic therapy for metabolic dysfunction-associated steatotic liver disease
{{output}}
The global epidemic of obesity has led to a surge in metabolic-associated steatotic liver disease (MASLD), which poses a significant global health burden. Current therapeutic strategies primarily focus on lifestyle modifications, weight loss interventions, and... ...